MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible Debenture Unit Offering

Each Debenture Unit consists of (i) $1,000 principal amount of senior unsecured convertible debentures (the "Debentures"); and (ii) common share purchase warrants (the "Warrants") exercisable for 1,000 common shares in the Company ("Shares").